Chris D. Hermann

Functional disparities within the TIMP family in cancer: hints from molecular divergence

A. Krüger, D. Häussler, Celina Eckfeld, 2019, Cancer and Metastasis Reviews.

Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy

H. Friess, A. Krüger, J. Krijgsveld, 2021, Journal of cachexia, sarcopenia and muscle.

TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer

A. Krüger, O. Soehnlein, P. Knolle, 2021, Cancer Research.

Identification of invariant chain CD74 as a functional receptor of tissue inhibitor of metalloproteinases-1 (TIMP-1)

A. Krüger, P. Knolle, F. Bayerl, 2021, The Journal of biological chemistry.

A novel tissue inhibitor of metalloproteinases‐1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients

H. Friess, A. Krüger, M. Martignoni, 2021, Journal of cachexia, sarcopenia and muscle.

TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer

A. Krüger, R. Khokha, P. Knolle, 2021, The Journal of experimental medicine.

TIMP-1 is a novel ligand of Amyloid Precursor Protein and triggers a proinflammatory phenotype in human monocytes

A. Krüger, P. Knolle, F. Bayerl, 2023, The Journal of cell biology.

Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses.

D. Schadendorf, A. Krüger, A. Obenauf, 2023, Immunity.